1. Home
  2. TCOM vs COR Comparison

TCOM vs COR Comparison

Compare TCOM & COR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

TCOM

Trip.com Group Limited

HOLD

Current Price

$70.87

Market Cap

45.9B

ML Signal

HOLD

Logo Cencora Inc.

COR

Cencora Inc.

HOLD

Current Price

$342.06

Market Cap

57.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TCOM
COR
Founded
1999
2001
Country
Singapore
United States
Employees
N/A
N/A
Industry
Hotels/Resorts
Other Pharmaceuticals
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
45.9B
57.4B
IPO Year
2003
N/A

Fundamental Metrics

Financial Performance
Metric
TCOM
COR
Price
$70.87
$342.06
Analyst Decision
Strong Buy
Buy
Analyst Count
9
13
Target Price
$80.00
$354.85
AVG Volume (30 Days)
2.2M
1.6M
Earning Date
11-17-2025
11-05-2025
Dividend Yield
0.42%
0.69%
EPS Growth
86.40
5.71
EPS
6.25
7.96
Revenue
$8,393,499,281.00
$321,332,819,000.00
Revenue This Year
$18.22
$7.04
Revenue Next Year
$13.73
$6.48
P/E Ratio
$11.33
$43.47
Revenue Growth
17.45
9.31
52 Week Low
$51.35
$223.92
52 Week High
$78.65
$377.54

Technical Indicators

Market Signals
Indicator
TCOM
COR
Relative Strength Index (RSI) 49.50 44.59
Support Level $69.86 $336.60
Resistance Level $72.07 $351.99
Average True Range (ATR) 1.03 7.51
MACD 0.10 -1.79
Stochastic Oscillator 62.74 19.89

Price Performance

Historical Comparison
TCOM
COR

About TCOM Trip.com Group Limited

Trip.com is the largest online travel agent in China and is positioned to benefit from the country's rising demand for higher-margin outbound travel as passport penetration is only 12% in China. The company generated about 79% of sales from accommodation reservations and transportation ticketing in 2024. The rest of revenue comes from package tours and corporate travel. Before the pandemic in 2019, the company generated 25% of revenue from international travel, which is important to its margin expansion. Most of sales come from its domestic platform, but the company is expanding its overseas business. The competes in a crowded OTA industry in China, including Meituan, Alibaba-backed Fliggy, Tongcheng, and Qunar. The company was founded in 1999 and listed on the Nasdaq in December 2003.

About COR Cencora Inc.

Cencora is one of three leading domestic pharmaceutical wholesalers. It sources and distributes branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers. It and McKesson and Cardinal Health constitute over 90% of the US pharmaceutical wholesale industry. Cencora also provides commercialization services for manufacturers of pharmaceuticals and medical devices, global specialty drug logistics (World Courier), and animal health product distribution (MWI Animal Health). Cencora expanded its international presence in 2021 by purchasing Alliance Healthcare, one of the leading drug wholesalers in Europe.

Share on Social Networks: